| Sumario: | Background: Adults with Type 2 diabetes mellitus and chronic kidney disease experience higher risk for progression to end stage kidney disease, which negatively impacts health, increases medical costs, and decreases quality of life. Objective: Determine if an audit and feedback intervention in a local nephrology clinic can increase provider adherence to a clinical practice guideline that supports the prescription of sodium glucose cotransporter‐2 inhibitors to delay progression of chronic kidney disease. Design: A pretest‐posttest design was used to determine if an audit and feedback tool delivered to providers at 3‐week intervals would increase provider adherence to the guideline recommendation over the course of 3 months. A clinical decision guide was provided to participants at the onset of the intervention with structured interviews accompanying the audit and feedback cycles. Participants: English speaking physicians and advanced practice providers were recruited from a local nephrology outpatient clinic in the southeastern United States. Measurements: To evaluate the significance of the intervention, a chi‐square test was used to evaluate the change in prescribing of SGLT‐2 inhibitors compared to the 3 months before the intervention. Logistic regression assisted with examining the relationship between the intervention and proportion of new SGLT‐2 inhibitor prescriptions. Results: In this setting, statistical analysis indicated that the intervention significantly increased prescription of SGLT‐2 inhibitors in adults with Type 2 diabetes and chronic kidney disease. Conclusion: The intervention significantly increased provider adherence to the clinical guideline. Additional implementation on a larger scale is warranted to validate findings and further investigate barriers to prescribing that were reported by participating providers.
|
|---|